Louisiana 2015 Regular Session

Louisiana Senate Bill SB170

Introduced
4/2/15  
Refer
4/2/15  
Refer
4/2/15  

Caption

Provides relative to Medicaid managed care. (gov sig) (OR INCREASE GF EX See Note)

Impact

The proposed law also mandates that dispensing fees for prescriptions provided by managed care organizations are determined based on data specific to the costs incurred by pharmacies while serving long-term care patients. This consideration of unique service requirements is intended to improve the financial viability of pharmacies caring for this patient demographic, ultimately enhancing the quality of care and access to prescriptions for long-term care residents.

Summary

Senate Bill 170 addresses important regulations concerning Medicaid managed care specifically for residents of long-term care facilities. The bill stipulates that the Department of Health and Hospitals (DHH) is prohibited from imposing limits on the number of prescriptions available to these residents, in accordance with the definitions set forth in the Social Security Act. By ensuring that managed care organizations cannot establish such limits, the bill aims to safeguard the accessibility of necessary medications for vulnerable individuals residing in long-term care facilities.

Sentiment

Overall, the sentiment surrounding SB 170 appears to be supportive, especially among advocates for the elderly and healthcare providers who emphasize the need for comprehensive medication access for long-term care residents. Supporters argue that the bill is crucial for ensuring that patients do not face arbitrary limits on their prescriptions, which can significantly impact their health and wellbeing. However, it also raises discussions about the funding and operation of Medicaid managed care systems, which may be points of contention in legislative discussions.

Contention

Despite the broad support for protecting medication access, the bill may encounter opposition regarding its financial implications for the Medicaid system. Critics may question the sustainability of healthcare funding, balancing the needs of long-term care residents with the potential strain on state resources. This debate reflects a complex tension in healthcare reform regarding how best to ensure comprehensive care while managing finite public resources effectively.

Companion Bills

No companion bills found.

Previously Filed As

LA SB163

Provides relative to Medicaid managed care. (gov sig) (RE SEE FISC NOTE GF EX)

LA HB492

Provides for an independent claims review process within the Medicaid managed care program (EN INCREASE GF EX See Note)

LA SB359

Provides relative to behavioral health. (gov sig) (OR INCREASE GF EX See Note)

LA SB185

Provides relative to Medicaid and certain managed health care organizations providing health care services to Medicaid beneficiaries. (1/1/14) (RR1 See Note)

LA SB41

Provides relative to the regulation of pharmacy benefit managers. (See Act) (EN INCREASE SG EX See Note)

LA HB393

Provides relative to prescription drug benefits of certain managed care organizations participating in the La. Medicaid coordinated care network program (RE1 INCREASE GF EX See Note)

LA SB194

Provides relative to pharmacy benefit managers. (gov sig)

LA HB763

Medicaid; provide for a separate managed care program for dental services and dental services providers.

LA HB309

Provides for cost containment, cost sharing, and long term services and supports in the Medicaid managed care program (OR SEE FISC NOTE GF EX)

LA HB129

Provides relative to Medicaid nonemergency transportation providers and services (OR INCREASE GF EX See Note)

Similar Bills

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

CA AB852

Health care practitioners: electronic prescriptions.

CA AB149

Controlled substances: prescriptions.

TX SB594

Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2246

Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.